TY - JOUR
T1 - GWAS identifies four novel eosinophilic esophagitis loci
AU - Sleiman, Patrick M. A.
AU - Wang, Mei-Lun
AU - Cianferoni, Antonella
AU - Aceves, Seema
AU - Gonsalves, Nirmala
AU - Nadeau, Kari
AU - Bredenoord, Albert J.
AU - Furuta, Glenn T.
AU - Spergel, Jonathan M.
AU - Hakonarson, Hakon
PY - 2014
Y1 - 2014
N2 - Eosinophilic esophagitis (EoE) is an allergic disorder characterized by infiltration of the oesophagus with eosinophils. We had previously reported association of the TSLP/WDR36 locus with EoE. Here we report genome-wide significant associations at four additional loci; c11orf30 and STAT6, which have been previously associated with both atopic and autoimmune diseases, and two EoE-specific loci, ANKRD27 that regulates the trafficking of melanogenic enzymes to epidermal melanocytes and CAPN14, that encodes a calpain whose expression is highly enriched in the oesophagus. The identification of five EoE loci, not only expands our aetiological understanding of the disease but may also represent new therapeutic targets to treat the most debilitating aspect of EoE, oesophageal inflammation and remodelling
AB - Eosinophilic esophagitis (EoE) is an allergic disorder characterized by infiltration of the oesophagus with eosinophils. We had previously reported association of the TSLP/WDR36 locus with EoE. Here we report genome-wide significant associations at four additional loci; c11orf30 and STAT6, which have been previously associated with both atopic and autoimmune diseases, and two EoE-specific loci, ANKRD27 that regulates the trafficking of melanogenic enzymes to epidermal melanocytes and CAPN14, that encodes a calpain whose expression is highly enriched in the oesophagus. The identification of five EoE loci, not only expands our aetiological understanding of the disease but may also represent new therapeutic targets to treat the most debilitating aspect of EoE, oesophageal inflammation and remodelling
U2 - https://doi.org/10.1038/ncomms6593
DO - https://doi.org/10.1038/ncomms6593
M3 - Article
C2 - 25407941
SN - 2041-1723
VL - 5
SP - 5593
JO - Nature communications
JF - Nature communications
ER -